Market Overview

BMO Capital Maintains Outperform on Isis Pharmaceuticals, Inc., Raises PT to $17.00


Latest Ratings for ISIS

Dec 2015Wells FargoInitiates Coverage onOutperform
Nov 2015Goldman SachsInitiates Coverage onNeutral
Nov 2015BarclaysMaintainsEqual-Weight

View More Analyst Ratings for ISIS
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings


Related Articles (ISIS)